Tetrahydrocannabinol News and Research

RSS

Low levels of oral cannabis induces psychosis

Recreational cannabis use has previously been associated with psychotic reactions even in clinical situations where cannabis is administered orally at low doses, now Swiss researcher Dr. Bernard Favrat and colleagues at Institut Universitaire de Medicine Legale in Lausanne have confirmed this in the first such report, in closely monitored subjects participating in a clinical trial.

4 Apr 2005

Marijuana use may increase the risk of ectopic (tubal) pregnancies

It is not known whether drugs that block or, in the case of marijuana, over-stimulate the CB1 receptor can cause ectopic pregnancy in humans. However, "our results raise caution for women of reproductive ages regarding the chronic use of marijuana for recreation or pain alleviation," the researchers concluded.

27 Sep 2004

THC in marijuana may block the spread of forms of cancer causing herpes viruses

The compound in marijuana that produces a high, delta-9 tetrahydrocannbinol or THC, may block the spread of several forms of cancer causing herpes viruses, University of South Florida College of Medicine scientists report.

22 Sep 2004

Researchers get a grip on marijuana

Now researchers at Stanford University School of Medicine are a step closer to understanding how the drug's active ingredients - tetrahydrocannabinol and related compounds, called cannabinoids - may exert their effects.

16 Sep 2004

The medical use of marijuana

The medical use of marijuana enjoys wide public support. More than 70% of respondents to recent surveys agree that marijuana should be available medically. Sources: Pew Research Center for the People & the Press conducted by Princeton Survey Research Associates. Feb. 14-19, 2001 and The Gallup Poll. March 19-21, 1999.

30 Jun 2004

New Canadian drug submission for cannabis-based medicine

GW Pharmaceuticals and Bayer HealthCare, Pharmaceuticals Division - Canada have announced that GW has submitted a New Drug Submission for Sativex®, a cannabis-based medicinal extract product, to Health Canada.

13 May 2004